Bioresorbable vascular scaffolds versus conventional drug-eluting stents across time: a meta-analysis of randomised controlled trials

BACKGROUND: Bioresorbable vascular scaffolds (BVS) were designed to reduce the rate of late adverse events observed in conventional drug-eluting stents (DES) by dissolving once they have restored lasting patency. OBJECTIVES: Compare the safety and efficacy of BVS versus DES in patients receiving per...

Descripción completa

Detalles Bibliográficos
Autores principales: Jackson-Smith, Elliot, Zioupos, Stephanie, Banerjee, Prithwish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Coronary Artery Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9615997/
https://www.ncbi.nlm.nih.gov/pubmed/36288820
http://dx.doi.org/10.1136/openhrt-2022-002107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9615997/
https://www.ncbi.nlm.nih.gov/pubmed/36288820
http://dx.doi.org/10.1136/openhrt-2022-002107

Ejemplares similares